Home › Asset managers › Compare 2025-2026 › John Hancock vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,192 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
John Hancock 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 23,447 | 16,121 | 375 | 6,951 | 97.7% | 87.3% |
| Board proposals | 19,371 | 12,912 | 325 | 6,134 | 97.5% | 86.8% |
| E&S shareholder proposals | 162 | 0 | 0 | 162 | n/a | 38.4% |
| Other items | 3,914 | 3,209 | 50 | 655 | 98.5% | 91.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
6,134 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | John Hancock | Brighthouse |
|---|---|---|---|---|---|---|
| 10X GENOMICS, INC. | June 4, 2026 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | FOR 6 funds |
Split 4 FOR, 1 ABSTAIN |
| 10X GENOMICS, INC. | June 4, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of an amendment to our Certificate of Incorporation, as amended, to increase the total number of authorized shares of our common stock, par value $0.001 per share, from 220,000,000 shares to 440,000,000 shares. Capital Structure |
Board | For | FOR 3 funds |
Split 1 FOR, 1 AGAINST |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. Compensation |
Board | For | AGAINST 3 funds |
Split 1 AGAINST, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval, on an advisory basis, of the compensation paid to our named executive officers in 2025. Say-on-Pay |
Board | For | FOR 5 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr. Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Jeffrey A. Graves Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Jim D. Kever Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: John J. Tracy Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Malissia R. Clinton Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| 3M COMPANY | May 12, 2026 | Advisory approval of executive compensation. Say-on-Pay |
Board | For | FOR 11 funds |
Split 4 FOR, 1 AGAINST, 6 ABSTAIN |
| 3M COMPANY | May 12, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as 3M's independent registered public accounting firm. Audit-related |
Board | For | FOR 8 funds |
Split 4 FOR, 1 AGAINST, 6 ABSTAIN |
| 8X8, INC. | July 25, 2025 | To approve, through an advisory vote, 8x8, Inc.'s executive compensation for the fiscal year ended March 31, 2025. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| 8X8, INC. | July 25, 2025 | To ratify the appointment of Grant Thornton LLP as 8x8, Inc.'s independent registered public accounting firm for the fiscal year ending March 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| A-MARK PRECIOUS METALS, INC. | November 12, 2025 | Advisory vote on executive compensation Say-on-Pay |
Board | For | Split 5 FOR, 1 AGAINST |
FOR 1 fund |
| A. O. Smith Corporation | April 13, 2026 | Proposal to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the corporation: Audit-related |
Board | For | FOR 8 funds |
Split 3 FOR, 2 ABSTAIN |
| A.P. MOELLER - MAERSK A/S | March 25, 2026 | Reelect Marika Fredriksson as Director Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 2 funds |
| A.P. MOELLER - MAERSK A/S | March 25, 2026 | Reelect Robert Maersk Uggla as Director Director Elections |
Board | For | Split 2 FOR, 2 ABSTAIN |
ABSTAIN 2 funds |
| A10 NETWORKS, INC. | April 22, 2026 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
Split 3 AGAINST, 1 ABSTAIN |
| A10 NETWORKS, INC. | April 22, 2026 | To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified. Tor R. Braham Director Elections |
Board | For | FOR 3 funds |
Split 2 FOR, 2 WITHHOLD |
| A10 NETWORKS, INC. | April 22, 2026 | To ratify the appointment of Grant Thornton LLP as our independent public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| AAON, INC. | May 12, 2026 | Election of Directors for a term ending in 2029: Caron A. Lawhorn Director Elections |
Board | For | FOR 6 funds |
Split 4 FOR, 2 ABSTAIN |
| AAON, INC. | May 12, 2026 | Election of Directors for a term ending in 2029: David R. Stewart Director Elections |
Board | For | FOR 6 funds |
Split 4 FOR, 2 ABSTAIN |
| AAON, INC. | May 12, 2026 | Election of Directors for a term ending in 2029: Stephen O. LeClair Director Elections |
Board | For | FOR 6 funds |
Split 4 FOR, 2 ABSTAIN |
| AAON, INC. | May 12, 2026 | Proposal to approve, on an advisory basis, a resolution on the compensation of AAON's named executive officers as set forth in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 2 ABSTAIN |
| AAON, INC. | May 12, 2026 | Proposal to ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 4 FOR, 2 ABSTAIN |
| AAR CORP. | September 16, 2025 | Advisory proposal to approve our Fiscal Year 2025 executive compensation Say-on-Pay |
Board | For | FOR 6 funds |
Split 4 FOR, 1 ABSTAIN |
| AAR CORP. | September 16, 2025 | Ratify the appointment of KPMG LLP as our independent registered public accounting firm for Fiscal Year 2026 Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 1 ABSTAIN |
| AB SAGAX | May 8, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | Split 1 FOR, 2 AGAINST |
AGAINST 2 funds |
| ABBOTT LABORATORIES | April 24, 2026 | Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees Compensation |
Board | For | FOR 8 funds |
Split 9 FOR, 3 AGAINST |
| ABBOTT LABORATORIES | April 24, 2026 | Ratification of Ernst & Young LLP As Auditors Audit-related |
Board | For | FOR 8 funds |
Split 9 FOR, 3 ABSTAIN |
| ABBOTT LABORATORIES | April 24, 2026 | Say on Pay - An Advisory Vote on the Approval of Executive Compensation Say-on-Pay |
Board | For | FOR 11 funds |
Split 9 FOR, 3 ABSTAIN |
| ABBVIE INC. | May 8, 2026 | Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 Audit-related |
Board | For | FOR 11 funds |
Split 10 FOR, 4 ABSTAIN |
| ABBVIE INC. | May 8, 2026 | Say on Pay - An advisory vote on the approval of executive compensation Say-on-Pay |
Board | For | FOR 14 funds |
Split 9 FOR, 1 AGAINST, 4 ABSTAIN |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Advisory vote to approve the compensation of the Company's named executive officers for the fiscal year ended January 31, 2026. Say-on-Pay |
Board | For | FOR 9 funds |
Split 4 FOR, 2 ABSTAIN |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 30, 2027. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 2 ABSTAIN |
| ABM INDUSTRIES INCORPORATED | March 25, 2026 | Advisory approval of our executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| ABM INDUSTRIES INCORPORATED | March 25, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ABN AMRO BANK NV | April 22, 2026 | AUTHORIZE BOARD TO EXCLUDE PREEMPTIVE RIGHTS FROM SHARE ISSUANCES Shareholder Rights and Defenses |
Board | For | Split 4 FOR, 2 AGAINST |
FOR 2 funds |
| ABSA GROUP LIMITED | June 2, 2026 | APPROVE REMUNERATION IMPLEMENTATION REPORT Say-on-Pay |
Board | For | Split 1 FOR, 4 AGAINST |
FOR 1 fund |
| ACADEMY SPORTS AND OUTDOORS, INC. | June 4, 2026 | Approval, on a non-binding advisory basis, of the fiscal 2025 compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADEMY SPORTS AND OUTDOORS, INC. | June 4, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | Split 2 FOR, 1 AGAINST |
Split 4 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | FOR 6 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 2 WITHHOLD |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 13, 2026 | THE APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE COMPANY'S 2026 PROXY STATEMENT. Say-on-Pay |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 13, 2026 | THE RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Andrew Kim Director Elections |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Barbara Trebbi Director Elections |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: John Paulson Director Elections |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Kelly Young Director Elections |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Robert Chersi Director Elections |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Ratification of the appointment of KPMG LLP as the registered public accounting firm of Acadian Asset Management Inc. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ACCEL ENTERTAINMENT, INC. | May 7, 2026 | Elect six (6) directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify. Karl Peterson Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 1 WITHHOLD |
| ACCEL ENTERTAINMENT, INC. | May 7, 2026 | Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Alan Jope Director Elections |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Arun Sarin Director Elections |
Board | For | FOR 16 funds |
Split 7 FOR, 1 AGAINST, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Jennifer Nason Director Elections |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Julie Sweet Director Elections |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Masahiko Uotani Director Elections |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Nancy McKinstry Director Elections |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Paula A. Price Director Elections |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Tracey T. Travis Director Elections |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To approve, in a non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 18 FOR, 1 AGAINST |
Split 7 FOR, 1 AGAINST, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To determine the price range at which Accenture can re-allot shares that it acquires as treasury shares under Irish law. Capital Structure |
Board | For | FOR 16 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To grant the Board of Directors the authority to issue shares under Irish law. Capital Structure |
Board | For | FOR 16 funds |
Split 8 FOR, 3 AGAINST |
| ACCENTURE PLC | January 28, 2026 | To grant the Board of Directors the authority to opt-out of pre-emption rights under Irish law. Capital Structure |
Board | For | FOR 16 funds |
Split 8 FOR, 3 AGAINST |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | FOR 4 funds |
Split 2 FOR, 1 AGAINST |
| ACCURAY INCORPORATED | November 13, 2025 | To conduct an advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCURAY INCORPORATED | November 13, 2025 | To elect three Class I directors named in the accompanying proxy statement to serve until our 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. Anne B. Le Grand Director Elections |
Board | For | FOR 2 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCURAY INCORPORATED | November 13, 2025 | To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 1 FOR, 1 ABSTAIN |
| ACI WORLDWIDE, INC. | June 2, 2026 | To elect the nine directors named in the accompanying proxy statement to our Board of Directors to hold office until the 2027 Annual Meeting of Stockholders; Adalio T. Sanchez Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 3 ABSTAIN |
| ACI WORLDWIDE, INC. | June 2, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026; Audit-related |
Board | For | FOR 5 funds |
Split 4 FOR, 3 ABSTAIN |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | AGAINST 5 funds |
Split 2 AGAINST, 2 ABSTAIN |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ACM RESEARCH, INC. | June 10, 2026 | Ratification of appointment of Ernst & Young Hua Ming LLP as independent auditor for year 2026. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| ACNB CORPORATION | May 5, 2026 | To elect four (4) Class 3 directors to serve for terms of three (3) years and until their successors are elected and qualified. Kimberly S. Chaney Director Elections |
Board | For | Split 5 FOR, 1 AGAINST |
FOR 1 fund |
| ACUITY INC. | January 21, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
Split 3 FOR, 1 ABSTAIN |
| ACUITY INC. | January 21, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| ACUSHNET HOLDINGS CORP. | June 8, 2026 | To approve, in a non-binding advisory vote, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| ACUSHNET HOLDINGS CORP. | June 8, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ACV AUCTIONS INC. | May 27, 2026 | Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders. Robert Hershberg, PhD, MD Director Elections |
Board | For | FOR 1 fund |
Split 1 FOR, 1 WITHHOLD |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026; Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To approve, on an advisory, non-binding basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 4 FOR, 2 ABSTAIN |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| ADEIA INC. | May 7, 2026 | To approve an amendment to the Amended and Restated 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by an additional 10,700,000 shares of common stock; and Compensation |
Board | For | FOR 5 funds |
Split 4 FOR, 1 AGAINST |
| ADIDAS AG | May 7, 2026 | APPROVE MANAGEMENT BOARD REMUNERATION POLICY Say-on-Pay |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
Page 1 of 62 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.